ReviewDiseases (Basel, Switzerland)2020

The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Hannah M Kohl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.